← Back to All Filings

Natera Officer Files Form 144 Notice for 29,423 Shares

Low SignificanceSeptember 2, 2026 at 9:05:39 PM UTC

Natera, Inc.

$NTRA144CIK: 0001604821

Subscribe to track NTRA

Premium users can add ticker alerts and receive realtime notification updates.

Filing Summary

Natera Officer Files Form 144 Notice for 29,423 Shares

Company: Natera, Inc. (NTRA) Form: Form 144 | Filed: 2026-09-02 Significance: Low

Insider: Solomon Moshkevich Relationship: Officer

Proposed Transaction: • Security: Common Stock • Shares to Sell: 29,423 • Source: RSU Vesting (Acquired 09/01/2026) • Approx Sale Date: 09/02/2026

Key Insight: Officer Solomon Moshkevich filed notice to sell 29,423 shares of common stock received from routine RSU vesting. The transaction represents roughly 0.02% of outstanding shares.

Comprehensive Analysis

SEC Filing Analysis: Natera, Inc. (NTRA)

Executive Summary

  • Trading Significance: Low
  • Key Takeaway: Officer Solomon Moshkevich filed a Form 144 notice covering the proposed sale of 29,423 common shares acquired via RSU vesting.
  • Market Impact: Neutral, as the proposed transaction represents a negligible fraction of total shares outstanding.

Company & Insider Overview

FieldValue
CompanyNatera, Inc.
TickerNTRA
CIK0001604821
Insider NameSolomon Moshkevich
RelationshipOfficer

Filing & Transaction Details

FieldValue
Form TypeForm 144
Notice Date2026-09-02
Approximate Sale Date2026-09-02
Security TypeCommon Stock
Proposed Shares to Sell29,423
Acquisition SourceRestricted Stock Units (RSUs)
BrokerETrade Corporation

Financial Impact Assessment

Transaction Materiality

MetricValue
Shares Proposed for Sale29,423
Shares Outstanding143,220,000
% of Shares Outstanding0.02%
Company Market Cap~$47.18B
Materiality AssessmentLow

Impact Evaluation

  • Market Cap Context: Across Natera's ~$47.18B market capitalization, a 29,423 share transaction is routine and standard executive equity monetization following an RSU vest.
  • Dilution & Concentration: The RSU grant settlement and subsequent sale represent ~0.02% of outstanding shares, posing virtually no market absorption friction or dilution risk.

Market Impact Analysis

  • Stock Direction: Neutral
  • Reasoning: Regular post-vesting Form 144 filings are common for corporate officers and do not indicate fundamental business shifts.
  • Volume & Sentiment: Minimal to no observable volume or sentiment impact expected given the small transaction size relative to average daily liquidity.
Topics:#SECFiling#Form144#NTRA#InsiderSelling#Natera#StockMarket#BiotechStocks

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is AI-generated from public SEC filings and may contain errors. It is for informational and educational purposes only and is not investment, legal, or tax advice.

The Filing Fool is not a registered investment adviser, broker-dealer, or financial planner. Nothing here is a recommendation or solicitation to buy, sell, or hold any security.

Always do your own due diligence and consult a licensed professional.